Using a tool to solve a protein's structure, for most researchers in the world of structural biology and computational chemistry, is not unlike using the Rosetta Stone to unlock the secrets of ancient ...

Modern software increasingly depends on data structures that go far beyond basic arrays and trees. Some of the most powerful systems rely on designs that rarely appear in traditional programming ...

Finance leaders across APAC face growing compliance pressure as fragmented systems create data integrity risks in multi-entity financial reporting.

Artificial intelligence (AI) companies may be booming, but they’re still struggling to get around a fundamental constraint: an insatiable demand for electricity. The federal government isn’t likely to ...

Voyager Technologies CEO Dylan Taylor said data centers in space will become a reality, but cooling issues still need to be resolved. Tesla CEO Elon Musk highlighted space-based data centers as a ...

An illustration shows a strand of engineered DNA passing through a nanoscale sensor, where its physical structure can be decoded as digital information. DNA nanostructures could one day serve as ultra ...

For the past two years, the conversation around AI infrastructure has focused on chips, models, and capital. In practice, that isn’t what’s slowing projects down. What matters is electricity–where it ...

America’s AI boom is pushing the nation’s largest power-grid operator to the brink of a supply crisis. Sixty-seven million people in a 13-state region stretching from New Jersey to Kentucky get their ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. My advice to leaders at Davos: AI doesn’t fail because of technology, it fails when we ...

When a federal court decertified a $20 billion class in In re Apple iPhone Antitrust Litigation in late October, it didn’t throw out a legal theory—it threw out a data model. Millions of iPhone users ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...